Franck Ceppa
Impact in
-
- Cholinesterase and Neurodegenerative Diseases
- Occupational Therapy top 10%
- Occupational Health and Performance
Papers in
- Pharmacology 12
- Cholinesterase and Neurodegenerative Diseases 9
-
- Pleural and Pulmonary Diseases 5
- Co-authors
- P. Burnat (29 shared papers)Hervé Delacour (20 shared papers)H. Mayaudon (10 shared papers)Olivier Dupuy (7 shared papers)B. Bauduceau (8 shared papers)Sofya V. Lushchekina (2 shared papers)Oksana Lockridge (2 shared papers)Patrick Masson (2 shared papers)
- Journals
- Diabetes & Metabolism (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Biochemical Pharmacology (1 paper)The Pharmacogenomics Journal (1 paper)Infection (1 paper)
- Partner nations
- FranceRussiaUnited States
In The Last Decade
Franck Ceppa
48 papers receiving 363 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 74
- Occupational Therapy 16
- Endocrinology, Diabetes and Metabolism 37
- Toxicology 8
- Cardiology and Cardiovascular Medicine 48
Countries citing papers authored by Franck Ceppa
This map shows the geographic impact of Franck Ceppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Ceppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Ceppa more than expected).
Fields of papers citing papers by Franck Ceppa
This network shows the impact of papers produced by Franck Ceppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Ceppa. The network helps show where Franck Ceppa may publish in the future.
Co-authors
The 25 scholars most cited alongside Franck Ceppa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 57 | |
| 2 | 2005 | 37 | |
| 3 | 2000 | 33 | |
| 4 | 2014 | 30 | |
| 5 | 2014 | 24 | |
| 6 | 2010 | 18 | |
| 7 | 2016 | 18 | |
| 8 | 2007 | 12 | |
| 9 | 2008 | 11 | |
| 10 | [The usefulness of adenosine deaminase determination in biological fluids for tuberculosis diagnosis]. | 2006 | 10 |
| 11 | Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes. | 2002 | 9 |
| 12 | 2005 | 9 | |
| 13 | 2007 | 9 | |
| 14 | 2002 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2007 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2005 | 5 | |
| 20 | [Sexual abuse and chemical submission, a present-day problem]. | 2002 | 5 |
About Franck Ceppa
Franck Ceppa is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Plant Science and Surgery, having authored 54 papers that have together received 379 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (9 papers), Pleural and Pulmonary Diseases (5 papers), Pesticide Exposure and Toxicity (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Computational Drug Discovery Methods (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Pneumonia and Respiratory Infections (2 papers) and Alcoholism and Thiamine Deficiency (2 papers). The work is most often cited by research in Pharmacology (74 citations), Occupational Therapy (16 citations), Endocrinology, Diabetes and Metabolism (37 citations), Toxicology (8 citations) and Cardiology and Cardiovascular Medicine (48 citations). Franck Ceppa has collaborated with scholars based in France, Russia and United States. Frequent co-authors include P. Burnat, Hervé Delacour, H. Mayaudon, Olivier Dupuy, B. Bauduceau, Sofya V. Lushchekina, Oksana Lockridge, Patrick Masson, Lawrence M. Schopfer and L. Bordier. Their work appears in journals such as Diabetes & Metabolism, Clinical Chemistry and Laboratory Medicine (CCLM), Biochemical Pharmacology, The Pharmacogenomics Journal and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.